## Summary
[PRRG2](/details-gene/5639) (Proline Rich and Gla Domain 2) encodes a single-pass transmembrane protein known as Transmembrane gamma-carboxyglutamic acid protein 2. Functionally, it is a vitamin K-dependent protein involved in processes such as [blood coagulation (GO:0007596)](https://www.ebi.ac.uk/QuickGO/term/GO:0007596) and [calcium ion binding (GO:0005509)](https://www.ebi.ac.uk/QuickGO/term/GO:0005509). Expression data highlights [PRRG2](/details-gene/5639) as a significant marker for specialized epithelial and secretory cell populations. It shows particularly high significance in [ionocytes](/details-cell/CL0005006), [intestine goblet cells](/details-cell/CL0019031), and [colon epithelial cells](/details-cell/CL0011108), suggesting a specialized role in mucosal tissues and ion transport.
## Cellular Roles and Expression Landscape
The expression profile of [PRRG2](/details-gene/5639) indicates a highly specialized function within specific epithelial and secretory cell lineages. **Overall**, the gene demonstrates the highest significance in cells responsible for secretion and ion exchange at barrier surfaces. Its top markers include [ionocytes](/details-cell/CL0005006) (CSI: 3.63), which are critical for ion transport, and mucus-producing cells of the gastrointestinal tract, such as [intestine goblet cells](/details-cell/CL0019031) (CSI: 2.85) and [colon epithelial cells](/details-cell/CL0011108) (CSI: 2.76).
This pattern of expression extends to other secretory cell types, including [club cells](/details-cell/CL0000158) (CSI: 2.45) in the respiratory tract and hormone-secreting [enteroendocrine cells](/details-cell/CL0000164) (CSI: 2.28) in the gut. Its localization to the [plasma membrane (GO:0005886)](https://www.ebi.ac.uk/QuickGO/term/GO:0005886) and [extracellular space (GO:0005615)](https://www.ebi.ac.uk/QuickGO/term/GO:0005615) is consistent with a role as a cell-surface receptor or signaling molecule in these specialized cellular contexts. The specificity of its expression suggests that [PRRG2](/details-gene/5639) is not a general housekeeping gene but rather a key component of the molecular machinery defining these particular cell identities.
## Pathways and Molecular Function
The functional annotations for [PRRG2](/details-gene/5639) point towards its involvement in calcium-dependent processes at the cell surface. Its annotation for [calcium ion binding (GO:0005509)](https://www.ebi.ac.uk/QuickGO/term/GO:0005509) is characteristic of proteins containing a gamma-carboxyglutamic acid (Gla) domain, which requires vitamin K for post-translational modification [Link](https://doi.org/10.1073/pnas.94.17.9058). This links its activity to the vitamin K cycle, which is essential for blood coagulation factors. Accordingly, [PRRG2](/details-gene/5639) is associated with the [blood coagulation (GO:0007596)](https://www.ebi.ac.uk/QuickGO/term/GO:0007596) biological process.
Research has further elucidated its molecular interactions, revealing that [PRRG2](/details-gene/5639) can function as a cell-surface protein that binds to the transcriptional coactivator Yes-associated protein (YAP), a central effector of the Hippo signaling pathway [Link](https://doi.org/10.1073/pnas.0703195104). This interaction suggests that [PRRG2](/details-gene/5639) may act as a sensor of the extracellular environment, translating external cues into intracellular signals that regulate cell proliferation, differentiation, and survival via YAP. The gene's additional annotations for [protein binding (GO:0005515)](https://www.ebi.ac.uk/QuickGO/term/GO:0005515) and potential [serine-type endopeptidase activity (GO:0004252)](https://www.ebi.ac.uk/QuickGO/term/GO:0004252) further support its role as an active participant in extracellular and cell-surface signaling events.
## Research Directions
The specific expression of [PRRG2](/details-gene/5639) in mucosal epithelial cells, combined with its function as a vitamin K-dependent, YAP-interacting protein, opens several avenues for investigation into its role in tissue homeostasis and disease.
**Proposed Hypotheses:**
1. Given its high expression in gut epithelial cells and its association with [blood coagulation (GO:0007596)](https://www.ebi.ac.uk/QuickGO/term/GO:0007596), [PRRG2](/details-gene/5639) may function at the mucosal-luminal interface to initiate localized clotting or wound-healing responses following epithelial damage, thereby helping to maintain barrier integrity.
2. As a cell-surface interactor of the transcriptional coactivator YAP [Link](https://doi.org/10.1073/pnas.0703195104), [PRRG2](/details-gene/5639) could act as a mechanosensor or chemosensor in [colon epithelial cells](/details-cell/CL0011108), modulating Hippo-YAP signaling to control cell proliferation and differentiation in response to changes in the gut environment. Dysregulation of this function could contribute to inflammatory bowel disease or colorectal cancer.
3. The high significance of [PRRG2](/details-gene/5639) in [ionocytes](/details-cell/CL0005006) and its [calcium ion binding (GO:0005509)](https://www.ebi.ac.uk/QuickGO/term/GO:0005509) capacity suggest it may play a role in regulating ion transport, potentially by stabilizing ion channel complexes or by acting as a calcium-dependent signaling node.
**Experimental Approach:**
To test the hypothesis that [PRRG2](/details-gene/5639) modulates YAP signaling in intestinal epithelium, a key experiment would be to use CRISPR-Cas9 to knock out [PRRG2](/details-gene/5639) in a human colon organoid model. These knockout organoids and isogenic wild-type controls could then be challenged with stimuli known to activate the Hippo pathway, such as alterations in matrix stiffness or treatment with bile acids. The functional readout would involve quantifying the nuclear localization of YAP via immunofluorescence and confocal microscopy, alongside RNA-sequencing to profile changes in the expression of canonical YAP target genes (e.g., *CTGF*, *CYR61*). This would directly assess whether [PRRG2](/details-gene/5639) is necessary for transducing specific extracellular signals to the YAP transcriptional program.
**Therapeutic Potential:**
As a transmembrane protein with a specific expression pattern, [PRRG2](/details-gene/5639) presents a plausible therapeutic target. Since the Hippo-YAP pathway is frequently hyperactivated in various cancers, including colorectal cancer, [PRRG2](/details-gene/5639) could be a target for **inhibition**. If it acts as an upstream activator of YAP, a monoclonal antibody or small molecule designed to block its ligand-binding site or its interaction with other cell-surface partners could suppress oncogenic YAP signaling specifically in tumors where [PRRG2](/details-gene/5639) is highly expressed. This targeted approach could offer greater specificity and fewer off-target effects compared to systemic inhibition of core Hippo pathway components.
Disclaimer: This in-silico analysis is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
